Inclusion Criteria:  Adult Patients from 18 to 65 years. Gender: both males and females (age and sex matched in both groups). Patients diagnosed with NAFLD via ultrasound (hepatic steatosis observation on ultrasound). Treatment free from choline supplementation for the past 3 months prior starting the therapeutic regimen.  Exclusion Criteria:  Other liver diseases as viral hepatitis (B or C) Alcohol consumption more than 40 g per week for the past 12 months, and life-time cumulative consumption more than 100 kg. Autoimmune liver disease Malignancy of any nature. Any systemic failure (cardiovascular, renal or respiratory) Patients with major psychiatric illness. Pregnant or lactating women. Diabetes mellitus .